No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Based in Bangkok, Thailand, Inter Pharma Public Company Limited specializes in the manufacturing, importing, and distribution of a wide array of health and dietary supplements designed for both human and animal use. The company's operations are divided into two primary segments: Human Healthcare and Animal Healthcare. Its Human Healthcare division provides a diverse range of items including medical supplies, nutritional therapy products, cosmetics, supplemental foodstuffs, probiotic and prebiotic offerings, health-focused and general food products, medical devices, and pharmaceutical medicines. This segment also extends to wellness and anti-aging solutions, aesthetic treatments like anti-wrinkle creams, hyaluronic fillers, and EGF cosmeceuticals, as well as diagnostic tools. For the Animal Healthcare sector, Inter Pharma caters to pets and livestock with veterinary provisions, nutritional support, vaccines, supplementary feeds, probiotic and prebiotic formulations, specialized animal health foods, premium and standard animal feeds, nutraceuticals, medicated shampoos, animal cosmeceuticals, and general pet and livestock food products. The company was founded in 2006 and is headquartered in Bangkok.

• Energenesis Biomedical CO.,LTD.
• Apex Biotechnology Corp.
• Cognition Therapeutics, Inc.
• Precision BioSciences, Inc.
• 3D Global Biotech Inc.
• JW (Cayman) Therapeutics Co. Ltd
• Ryvu Therapeutics S.A.
• Macrogen, Inc.